This episode is brought to you by Shopify.

That's what I hear when I make another sale on Shopify.

The all-in-one commerce platform that allows you to start, run and grow your business.

Shopify is revolutionising millions of businesses worldwide.

So sign up for a £1 per month trial period at Shopify.co.uk

Flash podcast 23 all lowercase and take your business to the next level today.

Mike Green, I'm here in Marin County and I'm reaching out across the world to my friend in London.

Christian Angermire, Christian, you and I have known each other for a number of years

through a couple of different vectors, through Steve Drobney, through Peter Teal.

You are an investor through your private family office, Aperon.

And in particular, we're here to talk about two companies that you've become involved with.

Compass and compass pathways and a tie life sciences.

Both of them are tied into the psychedelic space.

And so I've done other interviews around cannabis stocks, etc.

But this is a new move into an area that most investors have no exposure to or have very limited exposure to.

And that traditionally would have been thought of as very, very fringe.

But these two companies are doing something very mainstream.

Compass is extremely focused on the idea of psilocybin in the treatment of depression.

Magic mushrooms, the active ingredient in them.

And a tie brings that in a much broader sense,

basically exploring what have traditionally been used as recreational drugs or illicit drugs

and exploring their pharmaceutical properties for the treatment of a wide variety of conditions.

...